Royal Bank Of Canada Indaptus Therapeutics, Inc. Transaction History
Royal Bank Of Canada
- $422 Billion
- Q1 2024
Shares
1 transactions
Others Institutions Holding INDP
# of Institutions
18Shares Held
588KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA256KShares$543,2810.0% of portfolio
-
Investment House LLC Las Vegas, NV102KShares$217,1660.01% of portfolio
-
Geode Capital Management, LLC Boston, MA54.8KShares$116,1060.0% of portfolio
-
Strategy Asset Managers LLC45.3KShares$96,1120.02% of portfolio
-
Pine Valley Investments LTD Liability CO Marlton, NJ44.1KShares$93,5870.01% of portfolio
About Indaptus Therapeutics, Inc.
- Ticker INDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,258,600
- Market Cap $17.5M
- Description
- Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...